Designated Cancer definition

Designated Cancer means a disease manifested by the presence of a malignant tumor characterized by the uncontrolled growth and spread of malignant cells and invasion of tissue. Incontrovertible evidence of such invasion of tissue or definite histology, laboratory or radiology must be produced. The term "Designated Cancer" shall include leukemia and lymphoma but shall exclude pre-malignant tumors, non-invasive cancers in-situ, tumors in the presence of any Human Immunodeficiency Virus (HIV) and skin cancer other than malignant melanoma.
Sample 1Sample 2
Designated Cancer means (1) any malignant tumour
Sample 1
Designated Cancer means (1) any malignant tumour positively diagnosed with histological confirmation and characterized by the uncontrolled growth of malignant cells and invasion of tissue; or (2) any occurrence of histologically confirmed leukemia,lymphoma or sarcoma.
Sample 1

Examples of Designated Cancer in a sentence

  • Further, the designation seeks to increase national recognition of Florida organizations (e.g., as a National Cancer Institute Designated Cancer Center).

  • Stanford Medicine: A National Cancer Institute Designated Cancer Center.

  • This error is of particular importance, because MERCOSUR87 Supra, para.

  • Discharged/transferred to a Designated Cancer Center or Children's Hospital.

  • KUMC remains on track to apply for and achieve National Cancer Institute (NCI) Designated Cancer Center status in the next several years.

  • They are required to follow the UICC DSMP and CTO Internal Audit SOP or, if an NCI Designated Cancer Center, they may follow their own NCI approved Data and Safety Monitoring Plan.

  • If a study is UICC investigator-initiated, and not monitored by an independent DSMB or another DSMC at an NCI Designated Cancer Center, then it will adhere to the policies and processes described in this plan and the UICC DSMC will serve as the protocol’s DSMC and will adhere to the policies and processes described in the DSMP.

  • Designated Cancer Center shall mean a site approved by the National Cancer Institute (NCI) as a comprehensive cancer center, clinical cancer center, consortium cancer center, or an affiliate of one of these centers.

  • The following National Cancer Institutes – Designated Cancer Centers have specialized remote second opinion programs.

  • The designated critical illnesses include Amputation of Foot due to Diabetic Complications, Aortic Dissection, Cardiac Failure caused by Cardiomyopathy, Cardiac Failure caused by Primary Pulmonary Arterial Hypertension, Coronary Artery Bypass Graft (Open Chest Surgery), Designated Cancer, Eisenmenger’s Syndrome, Heart Attack, Kidney Failure, Major Organ Transplant, Replacement of Heart Valve, Stroke, Surgery for Disease of the Aorta, and Valvular Impairment caused by Infective Endocarditis.

Related to Designated Cancer

  • Designated chemical dependency specialist means a person

  • Stage-Four Advanced, Metastatic Cancer means a cancer that has spread from the primary or original site of the cancer to nearby tissues, lymph nodes, or other areas or parts of the body.

  • Distribution Compliance Period means the period that ends 40 days after the completion of the distribution of each Tranche of Notes, as certified by the relevant Dealer (in the case of a non-syndicated issue) or the relevant Lead Manager (in the case of a syndicated issue);

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.

  • Medical cannabis means the same as that term is defined in Section 26-61a-102.

  • Pivotal Clinical Trial means a pivotal human clinical trial of a Licensed Product with a defined dose or a set of defined doses of such Licensed Product designed to ascertain efficacy and safety of such Licensed Product for the purpose of enabling the preparation and submission of an MAA to the competent Regulatory Authorities in a country of the Territory, as further defined in 21 C.F.R. § 312.21(c) for the U.S., as amended from time to time, or the corresponding foreign regulations.

  • Source-image receptor distance means the distance from the source to the center of the input surface of the image receptor.

  • sickle cell disease means a hemolytic disorder characterized by chronic anemia, painful events, and various complications due to associated tissue and organ damage; "hemolytic" refers to the destruction of the cell membrane of red blood cells resulting in the release of hemoglobin.

  • inherited metabolic disease means a disease caused by an inherited abnormality of body chemistry for which testing is mandated by law;

  • PCP means Primary Care Provider.

  • Massive Multiauthor Collaboration Site (or “MMC Site”) means any World Wide Web server that publishes copyrightable works and also provides prominent facilities for anybody to edit those works. A public wiki that anybody can edit is an example of such a server. A “Massive Multiauthor Collaboration” (or “MMC”) contained in the site means any set of copyrightable works thus published on the MMC site.

  • Clinical Trial means a Phase I Clinical Trial, Phase II Clinical Trial or Phase III Clinical Trial, or any post-approval human clinical trial, as applicable.

  • Participating Prosthetic Provider means a Prosthetic Provider who has a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan to provide services to you at the time services are rendered.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • Phase I Clinical Trial means a study in humans which provides for the first introduction into humans of a product, conducted in normal volunteers or patients to generate information on product safety, tolerability, pharmacological activity or pharmacokinetics, or otherwise consistent with the requirements of U.S. 21 C.F.R. §312.21(a) or its foreign equivalents.

  • Phase III Clinical Trial means a large, controlled or uncontrolled Clinical Study that would satisfy the requirements of 21 CFR 312.21(c), intended to gather the additional information about effectiveness and safety that is needed to evaluate the overall benefit-risk relationship of the drug and to provide an adequate basis for physician labeling.

  • Designated caregiver has the meaning as set out in the Code. Disciplinary Action includes termination of this Agreement and suspension, expulsion and exclusion of the Student as those terms are defined in the Act. Fee means fees payable by the Parents to the School as per the Fee Schedule. Fee Schedule means the schedule of fees for Tuition, Accommodation and miscellaneous charges, which is available from the School on request and may be updated from time to time. Homestay has the meaning as set out in the Code.

  • Approved clinical trial means a phase I, phase II, phase III, or phase IV clinical trial that is conducted in relation to the prevention, detection, or treatment of cancer or other life-threatening disease or Condition and is described in any of the following:

  • Medical cannabis dispensary means an organization issued a

  • Designated Center means a State Development and Redevelopment Plan Center as designated by the State Planning Commission such as urban, regional, town, village, or hamlet.

  • Biological diversity means the variability among living organisms from all sources including, inter alia, terrestrial, marine and other aquatic ecosystems and the ecological complexes of which they are part; this includes diversity within species, between species and of ecosystems.

  • Motor-driven cycle means every motorcycle that has a gasoline engine that (i) displaces less than

  • Designated Computer means the computers and the upgraded computers thereof installed in the offices of the Licensee.

  • Development Candidate means a Compound that meets the Development Candidate Criteria for the initiation of a Development Program for the treatment of CF, and which is the subject of a notice from Vertex to CFFT that Vertex intends to commence formal pre-clinical development of the Compound in the Field pursuant to the provisions of Section 3.1 hereof.

  • Declared pregnant woman means a woman who has voluntarily informed the licensee or registrant, in writing, of her pregnancy and the estimated date of conception. The declaration remains in effect until the declared pregnant woman withdraws the declaration in writing or is no longer pregnant.